Cocrystal Pharma (COCP) FCF Margin (QoQ) (2010 - 2026)
Cocrystal Pharma (COCP) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Cocrystal Pharma | 16.41 Mn | 14.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -135,619.00 |
| Dec 31, 2020 | 16,280.00 |
| Sep 30, 2020 | -20,982.00 |
| Jun 30, 2020 | 7,476.00 |
| Mar 31, 2020 | -18,858.00 |
| Dec 31, 2019 | -1,394.00 |
| Sep 30, 2019 | -11,795.00 |
| Jun 30, 2019 | -21,357.00 |
| Jun 30, 2013 | -3,760.00 |
| Mar 31, 2013 | -287.00 |
| Dec 31, 2012 | -176.00 |
| Sep 30, 2012 | 1,013.00 |
| Jun 30, 2012 | 5,925.00 |
| Mar 31, 2012 | -4,030.00 |
| Dec 31, 2011 | -3,857.00 |
| Sep 30, 2011 | 3,131.00 |
| Jun 30, 2011 | 292.00 |
| Mar 31, 2011 | -2,032.00 |
| Dec 31, 2010 | 764.00 |